{"schema_version":"secwatch.filing_event.v1","accession":"0000785161-25-000028","form_type":"8-K","ticker":"EHC","cik":"0000785161","company_name":"Encompass Health Corp","filed_at":"2025-06-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:51.263061+00:00","generated_at":"2026-05-20T02:13:03.194505+00:00","sec_items":["7.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Encompass Health reaffirms FY2025 guidance ahead of investor meetings","bullets":["Reiterated FY2025 net operating revenue $5,850M-$5,925M.","Adjusted EBITDA reaffirmed at $1,185M-$1,220M.","Adjusted EPS from continuing ops reaffirmed at $4.85-$5.10.","Senior management to meet investors on June 4 and June 18, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0000785161-25-000028","json":"https://secwatch.observer/filing/0000785161-25-000028.json","markdown":"https://secwatch.observer/filing/0000785161-25-000028.md","text":"https://secwatch.observer/filing/0000785161-25-000028.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/785161/000078516125000028/0000785161-25-000028-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/785161/000078516125000028/ehc-20250603.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T02:13:03.194505+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}